HTD News and Press, John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest From 06/17/23

2023-06-17 09:00:00 ET Summary Retirees, by the very definition of retirement, need to be financially independent. However, even for folks who are several years away from retirement, it can offer great benefits. We will go over our strategy as to how a diversified income and growt...

2023-06-01 17:18:39 ET Summary The market is composed of the intelligence and emotions of its participants, millions of people whose judgments and assessments guide its prices. Right now, the market is dominated by the expectation of a recession, and any data is read in its antici...

MENLO PARK, Calif., May 03, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological disorders by modulating the effects of the hor...

2023-04-26 16:29:14 ET Summary Eighteen of the twenty-six titles in my total portfolio are CEFs, whose distributions may consist of income, capital gain or return of capital. In this article, I decided to examine the components of their distributions for early 2023, so as to under...

MENLO PARK, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report first quarter financial results and provide a corporate update on May 3, 2023. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:...

2023-04-18 16:31:50 ET Summary What helped out HTD in terms of performance last year is what is making for weaker performance this year. Financials took a hit last month with the bank failures, primarily representing HTD's preferred and corporate bond allocations. At the same ...

MENLO PARK, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (Nasdaq: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological disorders by modulating the effects of the h...

2023-04-03 11:59:27 ET Summary The world seeks complexity, but simplicity often trumps complexity. For my investment goals, I have made the choice to focus mainly on CEFs and ETFs, carefully weighing their merits and drawbacks. Those of us who invest in these income vehicles a...

MENLO PARK, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (Nasdaq: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological disorders by modulating the effects of the h...

2023-03-29 13:22:07 ET Summary Investors are desperately in need of income simply to maintain their lifestyles in today's inflationary environment. Eaton Vance Tax-Managed Buy-Write Opportunities Fund uses an interesting strategy of owning a portfolio of stocks and writing call op...